- Home
- A-Z Publications
- CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders)
- Previous Issues
- Volume 12, Issue 7, 2013
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) - Volume 12, Issue 7, 2013
Volume 12, Issue 7, 2013
-
-
Disruption of Glutamate-Glutamine-GABA Cycle Significantly Impacts on Suicidal Behaviour: Survey of the Literature and Own Findings on Glutamine Synthetase.
The aetiology of suicide is complex and still not completely understood. The present communication, which consists of two parts, aims to shed some light on the role of amino acidergic neurotransmission in suicide. In the first part we provide an overview of the literature showing that with the exception of certain gamma-aminobutyric acid transporters, virtually all components of the glutamate-glutamine- gamma-aminobut Read More
-
-
-
Volumetric Analysis of the Hypothalamus, Amygdala and Hippocampus in Non-Suicidal and Suicidal Mood Disorder Patients – A Post-Mortem Study
In recent years, the hypothalamus, amygdala and hippocampus have attracted increased interest with regard to the effects of stress on neurobiological systems in individuals with depression and suicidal behaviour. A large body of evidence indicates that these subcortical regions are involved in the pathogenetic mechanisms of mood disorders and suicide. The current neuroimaging techniques inadequately resolve the Read More
-
-
-
The Role of Neuroimaging in Our Understanding of the Suicidal Brain
Authors: Stefanie Desmyter, Stijn Bijttebier and Kees v. HeeringenThis paper provides a review of the literature on neuroimaging studies of suicidal behaviour, and discusses the relevance of these studies for our understanding of suicidal behaviour. Main findings from molecular imaging studies include a reduced prefrontal perfusion or metabolism and a blunted increase in activation when challenged in association with a history of suicide attempts. Moreover, impairment of the prefrontal Read More
-
-
-
Postmortem-Assessed Impairment of Neuronal Activity in Depression: The Dominant Impact of Suicide
Authors: Tomasz Gos, Johann Steiner, Zbigniew Jankowski and Bernhard BogertsWe report recent postmortem findings from the Magdeburg Brain Bank related to the evaluation of impaired activity of neuronal networks relevant for depression. Chronic changes in ribosomal DNA transcriptional activity have been revealed by the quantitative evaluation of silver-stained nucleolar organising regions (AgNORs). Abnormalities in AgNOR parameters have been found in neurons of the prefrontal limbic regions Read More
-
-
-
Risk Factors for Suicide – An Alternative View
Authors: Tim J. Krause, Bernhard Bogerts and Axel GenzDuring the past years suicide statistics in Germany showed a dramatic decrease of suicide rates. Such a reduction in a comparatively short time period is not explainable by an altered frequency of major psychiatric disorders or certain neurobiological conditions that may underlie suicide; other factors causing or leading to suicide and their modification have to be considered. This overview illustrates various risk factors for Read More
-
-
-
Signal Transduction Abnormalities in Suicide: Focus on Phosphoinositide Signaling System
More LessSuicide is a major public health concern and each year about one million people die by suicide worldwide. Recent studies suggest that suicide may be associated with specific neurobiological abnormalities. Earlier studies of neurobiology of suicide focused on abnormalities of the serotonergic mechanism. These studies suggested that some serotonin receptor subtypes may be abnormal in the postmortem brain of suicide victi Read More
-
-
-
Hypothalamic Pituitary Adrenal Axis and Prolactin Abnormalities in Suicidal Behavior
Hypothalamic-Pituitary-Adrenal (HPA) axis hyperactivity measured with the dexamethasone suppression test and the dexamethesone/CRH test may have some predictive power for suicidal behavior in patients with mood disorders. Increased prolactin (PRL) levels may be related both to physiological and pathological conditions. HPA-axis abnormalities and increased levels of PRL may coexist, and common neuroendocrine Read More
-
-
-
Possible Impact of Microglial Cells and the Monocyte-Macrophage System on Suicidal Behavior
Immune dysfunction, including monocytosis, increased blood levels of interleukin-1 (IL-1), interleukin-6 (IL- 6) and tumor necrosis factor-alpha (TNF-alpha), as well as an increased microglial density in certain brain areas, have been described in schizophrenia and depression. Interestingly, similar immune alterations have been observed in suicide patients regardless of their underlying psychiatric diagnosis. This review summarizes Read More
-
-
-
Suicide and the Polyamine System
Authors: Jeffrey A. Gross and Gustavo TureckiSuicide is a significant worldwide public health problem. Understanding the neurobiology is important as it can help us to better elucidate underlying etiological factors and provide opportunities for intervention. In recent years, many lines of research have suggested that the polyamine system may be dysregulated in suicidal behaviors. Initial research in animals provided evidence of a dysfunctional polyamine stress response sy Read More
-
-
-
Effects of Palmitoylethanolamide and Luteolin in an Animal Model of Anxiety/Depression
The antidepressant effect of a compound formed by co-ultramicronized palmitoylethanolamide (PEA) and luteolin (PEA+luteolin) was investigated in a mouse model of anxiety/depressive-like behavior. 129Sv/Ev mice were subjected to 6 weeks of corticosterone administration, and then behavior, neurogenesis, neuroplasticity, neurotrophic and apoptotic proteins expression were evaluated. The effect of PEA+luteolin compound tre Read More
-
-
-
Multiple Intranigral Unilateral LPS Infusion Protocol Generates a Persistent Cognitive Impairment without Cumulative Dopaminergic Impairment
Inflammation in Parkinson’s disease (PD) is a continuous process and might be implicated in the progression of neuronal degeneration. Taking this into account, we proposed a new protocol with multiple and consecutive intranigral lipopolysaccharide (LPS) administration in order to analyze its effects on cognitive behavior. Additionally, striatal concentrations of the neurotransmitters dopamine (DA) and serotonin and their respe Read More
-
-
-
Rosuvastatin may have Neuroprotective Effect on Spinal Cord Ischemia Reperfusion Injury
Authors: Celal Yavuz, Sinan Demirtas, Orkut Guclu, Oguz Karahan, Ahmet Caliskan, Suleyman Yazici and Binali MavitasIschemia reperfusion injuries can be threatening to end organ viability and can progress, with mortal and morbid outcomes. In particular, neural tissues are highly sensitive to hypoxia and reperfusion stress. This study aimed to determine the neuroprotective effects of rosuvastatin on spinal cord ischemia reperfusion injury. Forty male Sprague– Dawley rats were divided into four equal groups: group I (control), group II (sham Read More
-
-
-
Motor Complications in Parkinson’s Disease: A Comprehensive Review of Emergent Management Strategies
Authors: Susana M. d. Sousa and João MassanoMotor complications (dyskinesias and motor fluctuations) are a common and disabling problem of dopaminergic therapy in Parkinson’s disease, which are often difficult to treat with the current therapeutic strategies. It has been proposed that continuous dopaminergic delivery could reduce the emergence of motor complications, which has been tried with levodopa intestinal infusion or subcutaneous apomorphine infusion. In Read More
-
-
-
Probenecid: An Emerging Tool for Neuroprotection
Authors: Ana L. Colín-González and Abel SantamaríaProbenecid (PROB) has been widely used for long time for different clinical purposes, from gout treatment to designs as a coadjutant for antibiotic agents. Among its many properties, the ability of PROB to preserve high concentrations of several metabolites and other agents in the CNS, together with its relative lack of side-effects, have made this drug a valuable pharmacological tool for clinical and basic research. Nowa Read More
-
-
-
Small Molecules Activating TrkB Receptor for Treating a Variety of CNS Disorders
Authors: Yan Zeng, Xiaonan Wang, Qiang Wang, Shumin Liu, Xiamin Hu and Shawn M. McClintockThe brain-derived neurotrophic factor (BDNF) and its high affinity receptor tropomyosin-receptor-kinase B (TrkB) play a critical role in neuronal differentiation and survival, synapse plasticity, and memory. Indeed, both have been implicated in the pathophysiology of numerous diseases. Although the remarkable therapeutic potential of BDNF has generated much research over the past decade, the poor pharmacokinetics Read More
-
Volumes & issues
-
Volume 24 (2025)
-
Volume 23 (2024)
-
Volume 22 (2023)
-
Volume 21 (2022)
-
Volume 20 (2021)
-
Volume 19 (2020)
-
Volume 18 (2019)
-
Volume 17 (2018)
-
Volume 16 (2017)
-
Volume 15 (2016)
-
Volume 14 (2015)
-
Volume 13 (2014)
-
Volume 12 (2013)
-
Volume 11 (2012)
-
Volume 10 (2011)
-
Volume 9 (2010)
-
Volume 8 (2009)
-
Volume 7 (2008)
-
Volume 6 (2007)
-
Volume 5 (2006)
Most Read This Month
Article
content/journals/cnsnddt
Journal
10
5
false
en

Most Cited Most Cited RSS feed
-
-
A Retrospective, Multi-Center Cohort Study Evaluating the Severity- Related Effects of Cerebrolysin Treatment on Clinical Outcomes in Traumatic Brain Injury
Authors: Dafin F. Muresanu, Alexandru V. Ciurea, Radu M. Gorgan, Eva Gheorghita, Stefan I. Florian, Horatiu Stan, Alin Blaga, Nicolai Ianovici, Stefan M. Iencean, Dana Turliuc, Horia B. Davidescu, Cornel Mihalache, Felix M. Brehar, Anca . S. Mihaescu, Dinu C. Mardare, Aurelian Anghelescu, Carmen Chiparus, Magdalena Lapadat, Viorel Pruna, Dumitru Mohan, Constantin Costea, Daniel Costea, Claudiu Palade, Narcisa Bucur, Jesus Figueroa and Anton Alvarez
-
-
-
- More Less